<DOC>
	<DOCNO>NCT01098396</DOCNO>
	<brief_summary>Gait disturbance common major cause lose independency patient advance Parkinson 's Disease ( PD ) . The medical treatment gait disturbance advance PD difficult many case classical dopaminergic treatment clinical benefit even worsen instability increase fall . Rasagiline , new MAO-B inhibitor recently approve world treatment early late stage PD suggest special effect gait patient advance PD ( LARGO sub-study ) .</brief_summary>
	<brief_title>Rasagiline Gait Treatment</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Rasagiline</mesh_term>
	<criteria>Patients PD experience motor response fluctuation gait disturbance ON OFF ( TUaG &gt; 10 sec ON 14 sec OFF ) treat stable dose antiparkinsonian medication last month . Patients must able identify situation Able walk 2 minute OFF ON state Nondemented ( MMSE= &gt; to25 ) Severe orthopedic problem Orthostatic hypotension basal visit Severe , troublesome ON dyskinesia Dementia ( MMSE &lt; 25 ) Major depression Active psychosis antipsychotic medication Patients unlikely complete full protocol . Patients tried rasagiline stop side effect lack symptomatic effect Treatment selegiline last 2 month Any contraindication accord SmPC</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>parkinson disease</keyword>
	<keyword>gait</keyword>
</DOC>